NEW STETIC ACRYLICS
K102874 · New Stetic · EBI · Mar 28, 2011 · Dental
Device Facts
| Record ID | K102874 |
| Device Name | NEW STETIC ACRYLICS |
| Applicant | New Stetic |
| Product Code | EBI · Dental |
| Decision Date | Mar 28, 2011 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3760 |
| Device Class | Class 2 |
Intended Use
The intended use of New Stetic® Acrylics is for the repair or fabrication of the denture base.
Device Story
New Stetic Acrylics is a denture base system consisting of monomer liquid and polymer powder components. The system is used by dental professionals to fabricate or repair denture bases. The process involves mixing the powder and liquid components at a prescribed ratio to create a dough-like material, which is then packed into a flask and cured in a water bath. The device is intended to provide a stable, durable denture base that meets mechanical requirements for flexural strength and modulus. The output is a finished denture base or repair, which benefits the patient by restoring dental function and aesthetics. The device is used in a dental laboratory or clinical setting.
Clinical Evidence
Bench testing only. The device was evaluated against ANSI/ADA Specification No. 12:2002/ISO 1567:1999. Testing included water absorption, solubility, flexural strength, flexural modulus, and residual monomer content. Results for heat-polymerized acrylics showed flexural strength of 70.8 MPa (min 65 MPa) and flexural modulus of 5300 MPa (min 2000 MPa). Results for self-polymerized acrylics showed flexural strength of 65.4 MPa (min 60 MPa) and flexural modulus of 3700 MPa (min 1500 MPa). All results met or exceeded required limits.
Technological Characteristics
Denture base resin system consisting of monomer liquid and polymer powder. Curing via water bath. Complies with ANSI/ADA Specification No. 12:2002/ISO 1567:1999. Manufacturing conforms to ISO 9001:2008 and ISO 13485:2003. Mechanical properties verified using INSTRON testing machines.
Indications for Use
Indicated for the repair or fabrication of denture bases.
Regulatory Classification
Identification
A denture relining, repairing, or rebasing resin is a device composed of materials such as methylmethacrylate, intended to reline a denture surface that contacts tissue, to repair a fractured denture, or to form a new denture base. This device is not available for over-the-counter (OTC) use.
Predicate Devices
- Myersons Economy Denture Base Material (K970522)
Related Devices
- K130076 — PROMOLUX, PROMOLUX HI, WEROPRESS, PREMECO PCS · Merz Dental GmbH · Aug 22, 2013
- K220680 — Denture Base Polymers · Shandong Huge Dental Material Corporation · Aug 12, 2022
- K052073 — FUTURAPRESS LT, N AND HP, FUTURAJET, FUTURASELF, FUTURAGEN AND FUTURACRYL 2000 · Schutz-Dental GmbH · Oct 26, 2005
- K082153 — MAJOR.REPAIR · Major Prodotti Dentari S.P.A. · Nov 25, 2008
- K131036 — YAMAHACHI DENTURE BASE RESINS · Yamahachi Dental Manufacturing Co. · Jul 12, 2013
Submission Summary (Full Text)
{0}------------------------------------------------
K102874
# 510(k) SUMMARY (as required by 807.92(c))
Regulatory Correspondent: Regulatory and Marketing Services Inc 962 Allegro Lane Apollo Beach, FL, 334570 Arthur Ward award@ajwtech.com 813-645-2855 813-677-4787 Submitter of 510(k): New Stetic Carrera 33, No. 50-09 Guarne, Antioquia, Colombia Edna Cecilia Gil EcGil@newstetic.com Date of Summary: 9/1/2010 Trade/Proprietary Name: New Stetic Acrylics New Stetic Denture Base Resins Classification Name: Resin, Denture, Relining, Repairing, Rebasing Product Code: EBI Intended Use: The intended use of New Stetic® Acrylics is for the repair or fabrication of the denture base. Device Description: The product is a denture system consisting of monomer and polymer powder and liquid components. Predicate Device: K970522 - Myersons Economy Denture Base Material. . Substantial Equivalence: New Stetic claims the proposed devices to be substantially equivalent to the devices previously cleared by FDA in K970522. New Stetic claims this equivalence because the proposed devices have an
MAR 2 8 2011
{1}------------------------------------------------
equivalent intended use, manufacturing materials, operating principles and physical operational specifications as compared to the predicate devices. The similarities and differences between the proposed and predicate devices have been identified and explained in the comparison matrix which has been included in Section 12 of this submission. These differences have no effect on safety and effectiveness.
#### Performance Testing:
All testing that is required has been performed. The New Stetic Acrylics have been found to fall within the required limits of the testing. The test results can be found in both the Biocompatibility Testing (Section 15) and the Performance Testing (Section 18) of this submission.
{2}------------------------------------------------
# SUMMARY OF TEHCNOLOGICAL CHARACTERISTICS
Following chart shows a comparison of the method of using and the properties declared with respect to the homologous Myerson's economy denture base
| PRODUCT | Myerson's economy denture<br>base material. | New Stetic ®<br>Acrylics, New Stetic ®<br>Denture Base<br>Resins. | |
|--------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(K)<br>NUMBER | K970522 | Not yet assigned | |
| PARAMETERS | | SIMILARITIES | DIFFERENCES |
| Method of use | Curing is accomplished by<br>mixing the powder and liquid<br>components at a prescribed<br>ratio (21 g powder/10 ml of<br>monomer) yielding a dough-<br>like material which is the<br>packed into a flask. The flask<br>is then placed in a water bath<br>for curing at:<br><br>1. 90 minutes at<br>165°F followed by<br>30 minutes in<br>boiling water, or<br><br>2. Overnight at 165°F<br>for at least 9<br>hours. | Curing is<br>accomplished by<br>mixing the powder<br>and liquid<br>components at a<br>prescribed ratio (2<br>parts powder to 1<br>part of monomer by<br>weight) yielding a<br>dough-like material<br>which is the packed<br>into a flask. The<br>flask is then placed in<br>a water bath for<br>curing at:<br><br>90 minutes at<br>165°F followed by<br>30 minutes in<br>boiling water. | The only<br>difference is in<br>determining the<br>powder / liquid<br>ratio.<br><br>This difference is<br>related to<br>characteristics of<br>polymer particle<br>size, but not affect<br>the performance<br>of the medical<br>device about<br>ensuring safe use,<br>which is supported<br>by the fulfilling of<br>parameters<br>required by<br>standard ANSI /<br>ADA Specification<br>No. 12:2002 / ISO<br>1567:1999) |
| Experimental<br>results | | | |
| Flexure<br>Strength.<br>(65MPa<br>Minimum) | 74<br>according to ANSI/ADA<br>Specification No. 12:2002/ISO<br>1567:1999) | 70.8<br>according to ANSI/ADA<br>Specification No.<br>12:2002/ISO<br>1567:1999) | Within<br>specification |
| Flexural<br>Modulus<br>2000 MPa<br>Minimum | 2459<br>according to ANSI/ADA<br>Specification No. 12:2002/ISO<br>1567:1999) | 5300<br>according to ANSI/ADA<br>Specification No.<br>12:2002/ISO<br>1567:1999) | Within<br>specification |
{3}------------------------------------------------
### CONCLUSION
According to previous information products Myerson's Economy Denture Base Material ( K970522) and New Stetic ® Acrylics, New Stetic ® Denture Base Resins are technically similar in terms of mechanical properties and specifications related to its use, since both meet the requirements of ANSI / ADA Specification No. 12:2002 / ISO 1567:1999 for Denture Base Polymers, which ensures that the product can be used safely.
New Stetic ® Acrylics, New Stetic ® Denture Base Resins are equivalent to Myerson's Economy Denture Base Material
{4}------------------------------------------------
### SUMMARY OF NON-CLINICAL TESTING DATA
Physical properties of polymers are measured in New Stetic's Quality Control Laboratory by means of well-gauged high specialized equipment, according to ANSI/ADA Specification No. 12:2002/ISO 1567:1999 Polymers for Denture Bases.
The most relevant physical properties of Heat-polymerized and Self-polymerized polymers are showed in the following chart:
Heat-polymerized acrylics (Opti-cryl, Veracil, Novacryl, Poti-cryl Pour andEZ-cryl)
| Parameters | Requirements<br>ANSI/ADA<br>SPECIFICATION N°<br>12:2002/ISO 1567:2008 | Experimental results |
|--------------------------|-----------------------------------------------------------------------|----------------------|
| Absorption | Not higher than 32 µg/mm³ | 18.10 |
| Solubility in | Not higher than 1.6 µg/mm³ | 0.8 |
| Flexure Strength | 65 MPa Minimum | 70.8 |
| Flexural Modulus | 2000 MPa Minimum | 5300 |
| Residual Monomer Content | 2.2% Maximum (In weight) | 0.98 |
Self-polymerized acrylics (Duracryl, O-cryl and Fidelity)
| Parameters | Requirements | Experimental results |
|-----------------------------|-------------------------------|----------------------|
| Absorption | Not higher than 32<br>µg/mm³ | 19.50 |
| Solubility in | Not higher than 8.0<br>µg/mm³ | 5 |
| Flexure Strength | 60 MPa Minimum | 65.4 |
| Flexural Modulus | 1500 MPa Minimum | 3700 |
| Residual Monomer<br>Content | 4.5% Maximum (In weight) | 1.45 |
Other physical properties like color, polishing capacity, translucency, and porosity are evaluated qualitatively. These properties are inside accepted limits.
{5}------------------------------------------------
#### QUALITY ASSURANCE OF THIS PRODUCT
Acrylic resins are made from the highest quality raw materials through a completely standardized production process which conforms to ISO Standard 9001:2008 and ISO 13485:2003.
Moreover, in its Quality Control Laboratory, New Stetic verifies the fulfilling of ANSI/ADA Specification No. 12:2002/ISO 1567:1999 concerning the quality requisites for the finished product, using specialized equipment.
The most representative machines used for quality control are the following
- Water absorption and solubility: The amount of water that can be absorbed by acrylic resins or the amount of weight that they lose when submerged in water is accurately tested. Acrylic is not soluble in saliva or in any other oral fluid.
- Porosity:The surface of processed acrylics is free from imperfections and porosity.
- Flexural Strength and Flexural Modulus : The degree of distortion suffered by acrylic resins under the occlusion forces that are applied during the use is verified in an INSTRON Testing Machine. The force supported by a resin until its fracture is also measured. This aspect ensures the good clinical performance of resins.
- Translucency: An object placed at the opposite side of the test tube containing acrylic resin must be visible.
- Residual Monomer Content: The amount of monomer that remains after the making of a prosthesis must be minimum in order to avoid possible irritations of oral tissues.
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized image of an eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle image.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
New Stetic C/O Mr. Auther J. Ward Regulatory Correspondent Regulatory and Marketing Services, Incorporated 962 Allegro Lane Apollo Breach, Florida 33572
MAY 1 3 2011
Re: K102874 Trade/Device Name: New Stetic Acrylics Regulation Number: 21 CFR 272.3760 Regulation Name: Denture Relining Repairing or Rebasing Resin Regulatory Class: II Product Code: EBI, EBG Dated: March 14, 2011 Received: March 21, 2011
Dear Mr. Ward:
This letter corrects our substantially equivalent letter of March 28, 2011.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{7}------------------------------------------------
#### Page 2- Mr. Ward
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Susan Punner
/Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{8}------------------------------------------------
Indications for Use
510(k) Number (if known): K102874
Device Name: New Stetic Acryics
Indications for Use: The indication for use of the New Stetic® Acrtylics is for the repair or fabrication of the denture base.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Rurre
(Division Sign-Off)
Division of Anesthesiology, General Hospital Infection Control, Dental Devices
Page I of I
**510(k) Number:** K162874
Traditional 510k Submission - New Stetic Acrylics
2 of 626